Advanced Cancer Option Prostate Treatment

 Advanced Cancer Option Prostate Treatment Stage Four Prostate Cancer



 

 

You need to have javascript enabled to view this page correctly

All award winners must be prepared to participate in award publicity.The priority age group for the 2005/6 awards is those aged 11 to 20, but special consideration will also be given to applications by groups which provide services to those aged 11 and under.Judges are looking to support or fund specific projects, rather than contribute to general running costs.Send your nomination to Griffin Grants, News/Gazette, 39 Upper George Street, Luton, LU1 2RD. You can also email nominations to griffingrants@bedsnews.com Applying for a grant doesn't stop you from collecting News/Gazette community cash points

.


Veggie lovers could fare better in cancer fight

If you're a middle-aged man (or already past it) here's what should be on your menu today: tomato sauce, watermelon, stir-fried tofu and veggies, selenium and vitamin E. Wash it all down with a swig of green tea or pomegranate juice and you may be able to ward off prostate cancer.

New and better information is coming to light every day about ways to prevent this common disease. Since doctors are getting better at catching it early, fewer men are dying of prostate cancer. But one in six men will still develop the disease in their lifetime.



Eat your Veggies, Drink Tea

Luckily, if you are at risk, there are things you can do. Prevention may be as simple as eating better, exercising more and taking a few key supplements. Many of these remedies, which cut inflammation, may also help men struggling with a benign enlarged prostate.


North American Scientific Receives Notice of Nasdaq Listing Hearing

North American Scientific, Inc. (Nasdaq:NASI) today announced that it received a letter from The Nasdaq Stock Market ("Nasdaq") dated October 19, 2007 providing formal notice that the Nasdaq Listing Qualifications Panel will consider the Company's appeal of Nasdaq's delisting action announced by the Company on October 16, 2007 at a hearing scheduled for November 29, 2007.

The letter states that the delisting action will be stayed pending the issuance of a written determination by a Nasdaq Listing Qualifications Panel. The Company's common stock will remain quoted on The Nasdaq Global Market pending the outcome of the appeal under its current symbol "NASI".

While the Company is working diligently to meet the requirements for continued listing on The Nasdaq Global Market as promptly as possible, the Company can provide no assurances that a Nasdaq Listing Qualifications Panel will grant the Company's request for continued listing on The Nasdaq Global Market.



 

 

 

Link to us - Contact us